Pliant Therapeutics (PLRX) Net Equity Issued and Repurchased (2019 - 2020)
Pliant Therapeutics (PLRX) posted quarterly Net Equity Issued and Repurchased of $10.0 million for Q2 2020, up 71328.57% quarter-over-quarter from $14000.0 in Q3 2019.
Pliant Therapeutics (PLRX) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $10.0 million the latest figure, recorded in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 10.00 Mn |
| Jun 30, 2020 | 10.00 Mn |
| Sep 30, 2019 | 14,000.00 |
| Sep 30, 2019 | 14,000.00 |